Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy

Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy

Our objective was to analyze longitudinal cellular and humoral immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in people with multiple sclerosis (pwMS) on B-cell depleting treatment (BCDT) compared to pwMS without immunotherapy. We further evaluated the i...

Full description

Bibliographic Details
Main Authors: Christina Woopen, Marie Dunsche, Georges Katoul Al Rahbani, Anja Dillenseger, Yassin Atta, Rocco Haase, Catarina Raposo, Rosetta Pedotti, Tjalf Ziemssen, Katja Akgün
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Vaccines
Subjects:
SARS-CoV-2
vaccination
anti-CD20 therapy
multiple sclerosis
ocrelizumab
interferon-gamma release assay
Online Access:https://www.mdpi.com/2076-393X/11/9/1464

Internet

https://www.mdpi.com/2076-393X/11/9/1464

Similar Items